Literature DB >> 32483012

Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a systematic review and meta-analysis of observational epidemiologic studies.

Dongyu Zhang1, Yuzhi Xi2, Yilin Feng3.   

Abstract

Epidemiologic evidence regarding association of ovarian cancer risk with blood lipid level and hyperlipidemia is inconsistent. We aimed to synthesize available epidemiologic studies to disentangle associations of cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and hyperlipidemia with ovarian cancer risk. We searched PubMed, EMBASE, and Web of Science for eligible studies. A random-effects model was applied for synthesis. Heterogeneity was evaluated by a Chi-squared test for the Cochran Q statistic and the I-squared value. Subgroup analysis was conducted by design, study locale, and ovarian cancer case number. Sensitivity analysis was conducted for studies adjusting for certain covariates or with superior quality. To explore the potential dose-response relationship, we further synthesized effect measures of moderate levels of cholesterol, triglycerides, HDL-C, and LDL-C. Twelve studies (five cohort and seven case-control studies) were included. In primary meta-analysis, the synthesized risk ratio (RRpool) and 95% confidence interval (CI) suggested that high cholesterol was associated with an increased ovarian cancer risk (RRpool 1.22, 95% CI 1.01-1.48, Cochran P value: 0.40, I2: 0.5%). High HDL-C was associated with a lower ovarian cancer risk (RRpool 0.61, 95% CI 0.40-0.94, Cochran P value: 0.06, I2: 63.7%). We obtained nonsignificant associations for other exposures. Subgroup and sensitivity analyses yielded consistent results as the primary analysis. Only cholesterol showed marginally significant association in synthesis using moderate exposure levels (RRpool 1.18, 95% CI 0.99-1.42, Cochran P value: 0.51, I2: 0.0%). Our study suggests that high blood cholesterol is associated with an increased ovarian cancer risk, whereas the etiological significance of other exposures deserves more investigations.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32483012     DOI: 10.1097/CEJ.0000000000000597

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

Review 1.  Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome.

Authors:  Sheetal Hardikar; Mary C Playdon; Prasoona Karra; Maci Winn; Svenja Pauleck; Alicja Bulsiewicz-Jacobsen; Lacie Peterson; Adriana Coletta; Jennifer Doherty; Cornelia M Ulrich; Scott A Summers; Marc Gunter
Journal:  Obesity (Silver Spring)       Date:  2022-07       Impact factor: 9.298

2.  The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.

Authors:  Li Quan; Yongkang Liu; Wenjing Cui; Xinru Wang; Weixiao Zhang; Zhongqiu Wang; Chuangen Guo; Chao Lu; Feixiang Hu; Xiao Chen
Journal:  Lipids Health Dis       Date:  2022-07-16       Impact factor: 4.315

Review 3.  Influence of cholesterol on cancer progression and therapy.

Authors:  Shyamananda Singh Mayengbam; Abhijeet Singh; Ajay D Pillai; Manoj Kumar Bhat
Journal:  Transl Oncol       Date:  2021-03-19       Impact factor: 4.243

Review 4.  Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential.

Authors:  Chang-Feng Deng; Neng Zhu; Tan-Jun Zhao; Hong-Fang Li; Jia Gu; Duan-Fang Liao; Li Qin
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

5.  Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients.

Authors:  Xueyao Huang; Xuan Wei; Sijing Qiao; Xue Zhang; Rui Li; Shunxue Hu; Hongluan Mao; Peishu Liu
Journal:  Cancer Manag Res       Date:  2021-12-06       Impact factor: 3.989

6.  Application of Dynamic and Static Light Scattering for Size and Shape Characterization of Small Extracellular Nanoparticles in Plasma and Ascites of Ovarian Cancer Patients.

Authors:  Ksenija Kogej; Darja Božič; Borut Kobal; Maruša Herzog; Katarina Černe
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.